USPSTF 2020 recommends against screening for BV in pregnant women who are not at risk for preterm labor (D recommendation)

Question clinique

Should primary care clinicians screen asymptomatic pregnant women for bacterial vaginosis to prevent preterm birth?

L’Essentiel

In this updated 2020 review, the United States Preventive Services Task Force (USPSTF) found adequate evidence that testing can accurately identify bacterial vaginosis (BV) in pregnant women. However, the task force found no evidence of benefit from screening asymptomatic pregnant women who are not at increased risk of preterm birth. Although the likelihood of harm from screening is low, the task force concluded that primary care clinicians should not screen for BV in pregnant women who are not at risk of preterm birth (D recommendation). There is insufficient evidence to recommend for or against screening for BV in pregnant women who are at increased risk for preterm delivery (I statement). These recommendations are consistent with the 2008 USPSTF recommendations. 2c

Plan de l'etude: Practice guideline

Financement: Government

Cadre: Population-based

Reviewer

David C. Slawson, MD
Professor and Vice Chair of Family Medicine for Education and Scholarship
Atrium Health
Professor of Family Medicine, UNC Chapel Hill
Charlotte, NC